Functional lumbar myelography with iohexol.
The results of 25 functional lumbar myelographies with iohexol are reported. The image quality was good or excellent in all. The side effects were mostly mild and showed the same frequency as reported in lumbar and thoracic myelographies with metrizamide. A slight increase in the frequency of side effects was found in 13 patients with spinal repuncture 6 or 24 hours after the myelography. Vacuolized monocytes in ultracentrifuged CSF following repuncture was found in 5 patients. No EEG changes or serious complications were found. Iohexol is considered safe in intrathecal use.
D000328:Adult; D000368:Aged; D003287:Contrast Media / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging; D007463:Iodobenzoates; D007472:Iohexol; D008161:Lumbosacral Region; D008297:Male; D008875:Middle Aged; D009192:Myelography / Q000379:methods*; D012585:Sciatica / Q000139:chemically induced; D013130:Spinal Stenosis / Q000000981:diagnostic imaging; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007472:Iohexol